Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Using platelet growth factors can improve hair density in transplants, especially for those with fine hair.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Tacrolimus can cause hair loss in kidney transplant patients.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Corticosteroids effectively treated a 60-year-old man's skin condition.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

The model and estimator can predict drug exposure in kidney transplant patients well.

Many people in Jordan misuse topical steroids without proper knowledge, highlighting the need for better education and regulation.